Latest News about MRK
Recent news which mentions MRK
Why Personalis Shares Are Trading Higher Today
February 03, 2023
From Benzinga
Merck's Keytruda Plus Chemo Combo Aces Late-Stage Study In Advanced Endometrial Cancer Patients
February 03, 2023
Tickers
MRK
From Benzinga
Merck's Oral COVID-19 Treatment Might Be Linked To Spreading Mutations, Study Shows
February 03, 2023
Tickers
MRK
From Benzinga
The 7 Most Undervalued Dow Stocks to Buy in February 2023
February 02, 2023
From InvestorPlace
Why These 2 Stocks Made the Dow Miss the Market Rally
February 02, 2023
From Motley Fool
US Stocks Higher, NASDAQ Adds Over 230 Points
February 02, 2023
From Benzinga
Merck Beats On Q4 earnings, Anticipates Almost 80% Decline In COVID-19 Treatment Sales In 2023
February 02, 2023
Tickers
MRK
From Benzinga
This trader nailed two big market calls in 2022. She says investors are ‘being paid to wait’ so should steer clear of stocks for 2023.
February 02, 2023
From MarketWatch
Got $5,000? 3 Stocks to Hold for the Next 20 Years
February 02, 2023
From Motley Fool
Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?
February 02, 2023
From Benzinga
3 No-Brainer Dividend Stocks to Buy Hand Over Fist in 2023
February 01, 2023
From Motley Fool
From Benzinga
These 20 stocks led the January rally
January 31, 2023
From MarketWatch
7 Healthcare Stocks That Will Be Big Winners in 2023
January 31, 2023
From InvestorPlace
Down 14.5%, Is Pfizer Stock a Screaming Buy?
January 30, 2023
From Motley Fool
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
From Benzinga
Will This Billion-Dollar Acquisition Be a Smart Move for Merck?
January 27, 2023
Tickers
MRK
From Motley Fool
The 3 Best Biotech Stocks Under $1 to Buy for January
January 26, 2023
From InvestorPlace
2 Market-Beating Stocks to Buy in 2023 and Hold for 10 Years
January 26, 2023
From Motley Fool
How I'd Invest $50,000 for Retirement If I Had to Start From Scratch
January 26, 2023
From Motley Fool
Earn Dividends Every Month With These 3 Stocks
January 26, 2023
From Motley Fool
From Motley Fool
Tickers
MRK
From Motley Fool
Seagen's Tukysa Becomes First FDA-Approved Treatment For HER2-Positive Metastatic Colorectal Cancer
January 20, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.